Cargando…
The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life
PURPOSE: The aim of this study was to examine what personally mattered to 24 patients who received immuno-oncology (IO) therapy for stage IV non-small cell lung cancer (NSCLC), as well as their families and friends, to understand how they evaluated their cancer treatments and the determinants of the...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256093/ https://www.ncbi.nlm.nih.gov/pubmed/31950409 http://dx.doi.org/10.1007/s11764-020-00853-3 |